FindTrial
Sign In

Comparison of efficacy of Teneligliptin and Sitagliptin for glucose fluctuation in Type 2 diabetes

Comparison of efficacy of Teneligliptin and Sitagliptin for glucose fluctuation in Type 2 diabetes - Comparison of efficacy of Teneligliptin and Sitagliptin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022885
Enrollment
20
Registered
2016-06-25
Start date
2013-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Teneligliptin 20mg/day for 1 week Sitagliptin 50mg/day for 1 week

Sponsors

University of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabtes ovet 20 years who provided their informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients using oral diabetic therapy or insulin therapy, those with mild renal dysfunction (male:s-Cre>1.5, female:s-Cre>1.3), those with severe infectin, those with severe trauma and those with severe liver dysfunction (AST and ALT: 3 times the normal levels) were excluded.

Design outcomes

Primary

MeasureTime frame
Maximum glucose level after supper—

Secondary

MeasureTime frame
AUC over 140 mg/dl after supper 18-24, AUC over 140 mg/dl after supper 20-24, GLP-1 level at 30 minutes after load, IRI level at 2h after load—

Countries

Japan

Contacts

Public ContactAkira Kurozumi

University of Occupational and Environmental Health First Department of Internal Medicine, School of Medicine

akira@med.uoeh-u.ac.jp093-603-1611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026